Browse > Article

Clinical Implication of Serum Thyroglobulin in Recurred Papillary Thyroid Cancer at Neck Nodes  

Lee, Ha-Na (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Han, Myung-Woul (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Lee, Ho-Jun (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Roh, Jong-Lyel (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Nam, Soon-Yuhl (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Kim, Sang-Yoon (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Choi, Seung-Ho (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.27, no.1, 2011 , pp. 42-46 More about this Journal
Abstract
Background and Objectives : Serum stimulated thyroglobulin(stim Tg) was well-known for useful marker in detecting of recurrent or persistent papillary thyroid cancer after total thyroidectomy. Serum stim Tg level may be possibly related with recurrent tumor volume, but rarely studied. The purpose of this study was to examine the relationship between preoperative serum stim Tg level and recurrent tumor burden and to find additional clinical usefulness of stim Tg more than to detect a recurrence. Material and Methods : From January 2000 to December 2009, 40 patients who were operated due to neck recurrence of papillary thyroid cancer after total thyroidectomy were enrolled. All patients had preoperative stim Tg. We compared the clinical correlation of stim Tg and other variables to influence the preoperative stim Tg levels. Results : Preoperative stim Tg levels weren't correlated with site of recurrence, number of metastasis, maximal size, and presence of extra-capsular spread. But considerable increase of stim Tg more than 50ng/mL was identified in recurrence of lateral neck. Patients who have higher stim Tg level after surgery tend to be have higher preoperative stim Tg level. Conclusion : stim Tg was not elevated in 7.5% of recurrent PTC patients. Thus, other diagnostic modalities such as US may be important for these patients. If preoperative stim Tg was more than 50ng/mL, it may suggest recurrence in lateral neck and have less possibility to achieve postoperative biochemical remission.
Keywords
Stimulated thyroglobulin; Papillary thyroid cancer; Recur;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, et al. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab. In press;2011.
2 Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139:346-351.   DOI
3 Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, et al. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2008;93:4683-4689.   DOI   ScienceOn
4 Zucchelli G, Iervasi A, Ferdeghini M, Iervasi G. Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2009;53:482-489.
5 Black EG, Gassoni A, Gimlette TM, Harmer CL, Maisey MN, Oates GD, et al. Serum thyroglobulin in thyroid cancer. Lancet. 1981;2:443-445.
6 Herle AJ, Uller RP. Elevated serum thyroglobulin. A marker of metastasis in differentiated thyroid carcinomas. J Clin Invest. 1975;56:272-277.   DOI
7 Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.   DOI   ScienceOn
8 Hardy KJ, Walker BR, Lindsay RS, Kennedy RL, Seckl JR, Padfield PL. Thyroid cancer management. Clin Endocrinol. 1995;42:651-655.   DOI   ScienceOn
9 Bachelot A, Caileux AF, Klain M, Baudin E, Ricard M, Bellon N, et al. Relationship between tumor burden and serum thy-roglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid. 2002;12:707-711.   DOI   ScienceOn
10 Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Europ J Endocrinol. 1998;138:249-252.   DOI   ScienceOn